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Tumor growth is regulated by a balance between proliferation, growth arrest and cell death. In
this study, we have examined the expression of p27, cyclin D1, bcl-2, and bcl-x for evaluation of their roles in
colon carcinoma progression.
The levels of p27, cyclin D1, bcl-2, and bcl-x expression were examined by
immunohistochemistry in transitional normal mucosa adjacent to adenomas (n=30), adenomas (n=30),
transitional normal mucosa adjacent to adenocarcinomas (n=63), adenocarcinomas (n=63) and metastasis
(n=16). Standard streptavidin-biotin immunperoxidase method was used for immunostaining and the stained
slides were examined microscopically using semiquantitative criteria.
Normal mucosa expressed p27 protein and adenocarcinomas displayed a decrease in the expression
of this protein. Decreased expression of p27 was associated with tumor progression (p=0.026). Cyclin D1
staining was prominent in most of the adenocarcinomas and metastasis (p=0.042). Meanwhile, we could not find
any relation between p27 and cyclin D1 expression. Bcl-2 and bcl-x expression also did not show any statistically
significant correlation in tumor progression.
The results of this study indicate that reduced p27 and cyclin D1 protein levels play an
important role in progression of colon cancer. Bcl-2, and bcl-x expression were of no role.
Colon carcinoma, cell cycle, apoptosis
Tümör gelişimi proliferasyon, büyümede durma ve hücre ölümü arasındaki denge ile düzenlenir. Bu
çalışmada, kolon karsinomunun gelişimindeki rollerinin değerlendirilmesinde p27, siklin D1, bcl-2 ve bcl-x
expresyonunu inceledik.
p27, siklin D1, bcl-2 ve bcl-x expresyonunun düzeyleri, adenomlara komşu normal
mukozada (n=30), adenomlarda (n=30), adenokarsinomlara komşu normal mukozada (n=63),
adenokarsinomlarda (n=63) ve metastazlarda (n=16) immünohistokimyasal olarak incelendi. İmmün boyama
için standart streptavidin-biotin immünperoksidaz metodu kullanıldı ve boyanan slaytlar yarı kantitatif kriterler
kullanarak mikroskopik olarak incelendi.
Normal mukozada p27 protein ekspresyonu saptandı, adenokarsinomlar ise bu protein
ekspresyonunda azalma gösterdi. p27 ekspresyonunda azalma tümör progresyonu ile ilişkili idi (p=0,026). Siklin
D1 boyaması adenokarsinom ve metastazların çoğunda belirgindi (p=0,042). Bu arada, p27 ve siklin D1
ekspresyonu arasında herhangi bir ilişki saptamadık. Bcl-2 ve bcl-x ekspresyonu da tümör progresyonunda
istatistiksel olarak belirgin anlamlılık göstermedi.
Bu çalışmanın sonucu p27 ve siklin D1 protein düzeylerinin kolon kanserinin progresyonununda
önemli rolü olduğunu göstermektedir. Bcl-2 ve bcl-x ekspresyonunun ise rolü saptanmamıştır.
Kolon kanseri, hücre döngüsü, apopitoz
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Carcinoma of the large bowel is one of the most
common malignancies in the world and by far the most
common carcinoma of the gastrointestinal tract .
Development of colon carcinoma is characterized by
an accumulation of genetic changes in tumor cells.
There are many factors that determine the rate of colon
carcinoma progression.
Colorectal carcinoma development is a
multistep process. The development of carcinoma
from adenomatous lesions is referred to as the
adenoma-carcinoma sequence. Accumulation of
genetic changes in tumor suppressor genes and
oncogenes has been proposed to relate to the stages of
colorectal carcinogenesis.
As with other tumors alterations in cell cycle
regulatory mechanisms play an important role in
colorectal carcinoma development and tumor growth
is regulated by a balance between proliferation,
growth arrest, and cell death. Uncontrolled cell
proliferation is a main hallmark of cancer. Alterations
in the expression or activity of proteins that are
involved in cell cycle regulation are playing important
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roles in carcinoma progression . Cell cycle
progression is regulated by a series of cyclins; cyclin-
dependent kinases (CDKs) and regulation of these
kinases are also controlled by specific CDKs
inhibitors (CDKI) at different phases of the cell cycle.
The D-type cyclins like cyclin D1 are important in
regulating the G1 checkpoint in cell cycle. p27, a
member of the Cip/Kip family is a low molecular
weight CDKI, which is able to arrest cell cycle
progression by complexing CDKs and their activity.
p27 is essential in controlling cell proliferation in
many different tissues .
Apoptosis is a form of cell death which is
regulated at the gene level and plays a central role in
neoplastic transformation. The main group of genes
controlling apoptosis is the bcl family, which includes
both promoters and inhibitors. Bcl-2 protein
expression has been associated with shorter disease
free survival in some groups of patients with tumors.
Anti-apoptotic protein bcl-xseems to play a major role
in colorectal tumorigenesis and progression. A shift
from expression of bcl-2 to bcl-x has been
demonstratedduring progression of colorectal tumors,
and significant bcl-xoverexpression has been found in
the majority of colorectal cancer patients when
compared with the corresponding normal colonic
tissue.
In the present study, we investigated the
immunohistochemical expressions of p27, cyclin D1,
bcl-2, and bcl-x in adenomas, adenocarcinomas, and
metastasis and also adjacent transitional normal
mucosa to find their effects on progression of
colorectal carcinomas.
In the present study, the tissues obtained from a
total of 30 adenomas, 63 adenocarcinomas, and 16
adenocarcinoma metastasis between the years 1998
and 2006 were examined. The hematoxylin and eosin
(H&E) stained slides of each case were taken from the
pathology archives and reviewed in each tumor.
For each case, the most representative tumor
tissue block was chosen and 5 µm sections were taken
to polyL lysin coated slides for immunuhistochemical
s t a i n i n g . S t a n d a r d s t r e p t a v i d i n b i o t i n
immunperox idase method was used fo r
immunostaining with p27 (AM396, BioGenex, CA,
USA), cyclin D1 (Novo Castra, Newcastle, UK), bcl-2
(MS123, Neomarkers, CA, USA), and bcl-x (A3535,
Dako, Ely, UK) antibodies. Appropriate tissue
sections known to react with both antibodies as
positive controls for each primary antibody were also
stained simultaneously.
Cells that had nuclear staining were considered
to be positive for p27 and cyclin D1 and cytoplasmic
immunostaining were accepted as positive for bcl-2
and bcl-x. The amounts of immunopositive cells were
estimated semiquantitatively: grade 1+ corresponds to
10-50%, grade 2+ to 50-75%, and grade 3+ more than
75% positive cells (4).
Data were analyzed by computer software SPSS
for Windows 10.0. A p value <0.05 was considered
statistically significant. Stage, grade, and type of the
lesion (adenoma, adenocarcinoma, metastasis,
adjacent normal mucosa) were compared with
immunohistochemical scores by Pearson correlation
method. Paired comparisons between groups were
analyzed using Spearman test.
The gender distribution of our cases were 62
men and 47 women. The median age of the patients
was 63.5 years, with a range of 3699. The size of the
resected adenocarcinomas ranged between 1 and 15
cm (mean 5.66 cm). Four (6.3%) of the
adenocarcinomas were well differentiated, 46 (73%)
were moderately differentiated, and 13 (20.6%) were
poorly differentiated. According to the Astler Coller
classification, 11 (17.5%) were staged as B1; 31
(49.2%) were B2; one (1.6%) was C1; and 20 (31.7%)
were C2. The localizations of metastasis were liver in
13 and lungs in three.
Immunoreactivity for p27 was observed in 22 of
the 63 adenocarcinomas, 21 of the 30 adenomas and 5
of the 16 metastasis (Figure 1). None of the
adenocarcinomas and metastasis showed strong
immunoreactivity. There was a significant reduction
of p27 staining in adenocarcinomas and metastasis
when compared to normal mucosa and adenomas
(p=0.001). Strongly positive staining for p27 was
found dominantly in transitional normal mucosa
adjacent to adenocarcinomas. p27 was also correlated
with bcl-x expression (r=0.278, p=0.001).
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Figure 1. p27 immunohistochemical staining in colon
adenocarcinoma (x400).
Kolorektal Adenomlar ve Adenokarsinomlarda Hücre Siklusu
10
Cyclin D1 immunoreactivity was detected in 48
of 63 adenocarcinomas, 17 of 30 adenomas, and 10 of
the 16 metastasis (Figure 2). Although there was no
significant relation between cyclin D1 staining scores
and tumor grade, immunoreactivity was prominent in
most of the adenocarcinomas and metastasis (r=0.143,
p=0.042). Cyclin D1 also showed significant
correlation with bcl-2 and bcl-x (r=0.325, p=0.001 and
r=0.170, p=0.024, respectively). In statistical analysis,
there was also no relation between p27 and cyclin D1
expression.
Forty-one of 63 adenocarcinomas, 14 of 30
adenomas, 5 of 16 metastasis showed positive staining
with bcl-2, while 46 adenocarcinomas, 19 adenomas,
11 metastasis were positive with bcl-x. Tables 1 and 2
briefly demonstrate p values of paired comparisons
and immunoreactivity of the lesions.
None of the immunohistochemical markers
studied showed significant correlation with tumor
grade and stage. The distribution of the
immunohistochemical staining according to tumor
grade and stage is shown in Table 3.
Low p27 expression has been reported to be a
poor prognostic factor in a variety of human cancers
including prostate, lung, gastrointestinal tract cancers,
squamous cell carcinomas and has been found to play
role in the differentiation of pancreatic cancer .
Belluco demonstrated that the immunohistochemical
assessment of p27 protein provides prognostic
information in patients with stage II and III disease in
DISCUSSION
5-8
Figure 2. Immunostaining of cyclin D1 in colon
adenocarcinoma (x200).
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Table 2. Immunohistochemical staining of the lesions.
Adenoma Mucosa adjacent to
adenoma
Carcinoma Mucosa adjacent
to carcinoma
Metastasis
p27
N 30 30 63 63 16
None 9 6 41 42 11
+ 11 13 18 11 3
++ 9 9 4 6 2
+++ 1 2 - 4 -
Total positive 21 24 22 21 5
Cyclin D1
N 30 30 63 63 16
None 13 14 15 25 6
+ 6 7 12 9 3
++ 8 8 25 27 6
+++ 3 1 11 2 1
Total positive 17 16 48 38 10
Bcl-2
N 30 30 63 63 16
None 16 13 22 20 11
+ 5 9 23 17 2
++ 7 7 16 23 3
+++ 2 1 2 3 -
Total positive 14 17 41 43 5
Bcl-x
N 30 30 63 63 16
None 11 9 17 22 5
+ 10 9 19 24 9
++ 9 12 24 17 2
+++ - - 3 - -
Total positive 19 21 46 41 11
Cyclin D1 Bcl-2 Bcl-x
p27 r=0.021
p=0.788
r=-0.002
p=0.977
r=0.278
p<0.001
Cyclin D1 r=0.325
p<0.001
r=0.170
p=0.026
Bcl-2 r=-0.081
p=0.284
Table 1. Correlation between p27, cyclin D1, bcl-2, and bcl-x.
colorectal adenocarcinomas . The absence of p27
protein was independently associated with a shorter
relapse-free survival, overall survival and was
inversely correlated with tumor stage. Decreased p27
expression has been associated with large size tumor,
positive lymph nodes, and with poor survival. Loss of
p27 could be one of the factors responsible for the
development of metastases . Tornillo et al found out
that p27 expression was more frequent in left sided
tumors . It is evident that deregulation of p27 has a
profound effect on tumor progression and is found to
be an accurate and independent prognostic marker .
Although some authors recorded that >90% of
colorectal tumors expressed p27, in the present study,
we found positive staining in 34% of adenocarcinoma
cases and the staining was weaker than adenomas
indicating that p27 is down-regulated during the
neoplastic process. These results confirmed the
previous reports (12). According to the results of our
series, low expression of p27 was independent with
the stage of the disease; so its low expression or
absence may help us to identify aggressive tumor
behavior in localized disease.
Abnormal expression of cyclin D1 and cyclin E
have also been reported in a variety of malignancies
. Although some authors found that cyclin D1
failed to have prognostic significance , it was
mostly found to be overexpressed in colorectal
carcinomas . Moreover, it was overexpressed in
the lymph node metastasis at a higher frequency than
the primary lesion and so it was thought that this
protein might suggest a role in the metastatic process
. Immunohistochemical analysis of our study showed
cyclin D1 expression in 76.2% of adenocarcinomas
which is similar to previous studies . This cyclin D1
expression may be related with colorectal
carcinogenesis. However, there was no statistically
significant association between cyclin D1 expression
and tumor grade. Kristt also could not find any relation
with grade and concluded that increased cyclin D1
may be an early event in colorectal carcinogenesis and
only cyclin D1 overexpression is not likely to predict
biological behavior . Holland found that cyclin D1
was associated with tumor differentiation and noted
that patients expressing cyclin D1 had improved
survival . Overexpression of cyclin D1 might have
more important role in colon cancer progression and
other cyclins may be more important in tumor
differentiation. Cyclin D1 is inducible by a variety of
oncogene products. Multiple independent
mechanisms of cell cycle deregulation may be present
during colonic carcinogenesis, whereas other studies
have failed to find any correlation between cyclin D1
and cyclin E overexpression and the clinicopathologic
factors of colorectal cancer .
In some studies there was an association
between p27 and cyclin D1 expression indicating that
the balance between the two opposing regulators was
important for the end result of cell cycle progression.
We could not find any relation between p27 and cyclin
D1 expression, as reported in some other studies .
There is compelling evidence in the literature for p27
to be regarded as a tumor marker and this must be
examined in the light of its interactions with other
proteins, most notably cyclin E . In addition, p21
protein expression was correlated with the presence of
cyclin D1 suggesting a possible co-regulatory control
mechanism for these proteins .
Dysregulation of apoptosis is prominent in
colorectal carcinogenesis. A shift from expression of
bcl-2 to bcl-x has been demonstrated during
progression of colorectal tumors, and significant bcl-x
overexpression has been found in the majority of
colorectal cancer patients when compared with the
corresponding normal colonic tissue. These results
suggest that expression of both molecules might be a
useful prognostic marker in colorectal cancer .
Abnormal bcl-2 immunoreactivity has been observed
in early dysplastic and neoplastic lesions of the colon
and small intestine, suggesting that bcl-2 alterations
occur early in the sequence of molecular events,
leading to gastrointestinal neoplasia . Grizzle
hypothesized that the prognostic importance of bcl-2
expression may be limited to spesific subgroups of
patients as well as anatomic location of the tumor .
Although, several studies demonstrated that altered
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Table 3. Distribution of immunohistochemical staining according to the tumor grade and stage.
p27 Cyclin D1 Bcl-2 Bcl-x
+ - + - + - + -
Grade
Well 2 2 4 - 3 1 3 1
Moderate 16 30 35 11 30 16 35 11
Poor 4 9 9 4 8 5 8 5
Stage
A - - - - - - - -
B1 6 5 9 2 7 4 9 2
B2 10 21 23 8 20 11 21 10
C1 - 1 1 - 1 - - 1
C2 6 14 15 5 13 7 16 4
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expression of bcl-2 protein (or apoptotic markers) or
high expression of bcl-2 and low expression of bax
could be expected in some colonic cancers , bcl-2
and bcl-x expressions were not associated with
progression of colon carcinoma in the present study.
Their expression did not show any significant
correlation between various clinicopathological
parameters. Not only our study but also Paradiso’s
could not find clinically relevant associations between
markers controlling apoptosis and clinicopathological
parameters . Bukholm also found that bcl-2 and bax
were not of prognostic value .
One of the major goals of cancer therapy in
general is induction of apoptosis (cell death) in the
malignant cells. More targeted treatment modalities
such as gene therapy also hope to induce apoptosis.
p27 along with other apoptosis-regulating genes such
as p53, p21, E2F, PTEN, and Caspase, are all potential
targets for more specific, directed therapeutic regimes.
Several clinical trials are underway in which the
tumor-suppressor and apoptosis-inducing properties
of genes are being used in new and novel treatment
protocols .
The results of this study indicate that reduced
p27 protein levels and cyclin D1 overexpression play
an important role in progression of colon cancer. We
did not find a clear association between expression of
apoptosis related markers and prognostic features or
carcinoma progression. Controlling the activation and
progression of the apoptotic programme is a complex
cascade. Progress may depend on the participation of
other regulatory signals.
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